Table 1.
Baseline clinical and demographic characteristics of the patients
| Variable | All patients | |
|---|---|---|
| N = 151 | % | |
| Gender | ||
| Male | 58 | 38.4 |
| Mean age (years) | 55 ± 15 | |
| Weight (kg) | 63 ± 12 | |
| Neoplastic etiology | 116 | 76.8 |
| Hypertensiona | 51 | 33.8 |
| Coronary diseaseb | 3 | 2.0 |
| Diabetes mellitusc | 21 | 13.9 |
| Smoking (current + ex-smokers) | 84 | 56 |
| Pack-years | 19 | ±25 |
| Previous radiotherapy | 18 | 11.8 |
| Previous chemotherapy | 25 | 16.6 |
| Functional capacity (MET) | ||
| < 4 MET | 15 | 9.9 |
| ≥4 MET | 136 | 90.1 |
| EMAPO | ||
| Low | 125 | 82.8 |
| Moderate | 23 | 15.2 |
| High | 1 | 0.7 |
| Very high | 2 | 1.3 |
| ACP | ||
| Class I | 146 | 96.7 |
| Class II | 5 | 3.3 |
| Class III | 0 | 0 |
MET Metabolic Equivalent, EMAPO Risk score by the Estudo Multicêntrico de Avaliação Perioperatória (Multicentric Perioperative Evaluation Study), ACP Detsky risk score (American College of Physicians)
aSystolic blood pressure above 180 mmHg and/or diastolic blood pressure above 110 mmHg and/or patient who reports being hypertensive with or without the use of antihypertensive drugs
bPatients with angina pectoris, previous history of myocardial infarction, or previous surgical and/or percutaneous procedures for myocardial revascularization
cPatients who reported being diabetic with or without the use of medication or those who had a fasting serum glucose level > 126 mg/dl in preoperative tests